Ziopharm Oncology reported $10.32M in Loan Capital for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Amgen AMGN:US $ 35705M 305M
AstraZeneca AZN:LN 27146M 1659M
Baxter International BAX:US $ 16278M 487M
Biogen BIIB:US $ 6277.4M 1.7M
Bioline Rx BLRX:US $ 1.66M 0.07M
Bristol Myers Squibb BMY:US $ 37107M 343M
Corcept Therapeutics CORT:US $ 0M 0M
Curis CRIS:US $ 0M 0M
Eleven Biotherapeutics EBIO:US $ 0 0
GlaxoSmithKline GSK:LN 18784M 10442M
Intercept Pharmaceuticals ICPT:US $ 713.86M 3.03M
Karyopharm Therapeutics KPTI:US $ 302.69M 202K
Novartis NOVN:VX SF 23784M 589M
Ptc Therapeutics PTCT:US $ 981.44M 5.79M
Regeneron Pharmaceuticals REGN:US $ 2700.7M 0.3M
Sangamo Biosciences SGMO:US $ 0M 0M
Verastem VSTM:US $ 24.54M 0.13M
YTE INCY:US $ 31.16M 0.23M
Ziopharm Oncology ZIOP:US $ 10.32M 5.93M